From D. Boral Capital
News & Insights
Stay informed with transaction announcements, firm news, and strategic insights from D. Boral Capital.
Latest Updates
News & Insights
Published by D. Boral Capital
Press Release
D. Boral Capital Served as Exclusive Placement Agent to FAVO Capital, Inc. (OTC Pink: FAVO) in connection with its $2.0 Million Private Placement
Read More →
Press Release
D. Boral Capital Served as Co-Manager to ImmunityBio, Inc. (Nasdaq: IBRX) in connection with its $100.0 Million Underwritten Public Offering
Read More →
Press Release
D. Boral Capital acted as Exclusive Placement Agent to SRM Entertainment, Inc. (Nasdaq: SRM) in connection with its $1.7 Million Registered Direct Offering
Read More →
Press Release
D. Boral Capital Acted as Exclusive Placement Agent to Armlogi Holding Corp. (Nasdaq: BTOC) in connection with its up to $21 Million Convertible Promissory Notes and $50 Million Standby Equity Purchase Agreement
Read More →Press Release
D.Boral Capital Advises Nova Vision Acquisition on $64M Business Combination
Read More →Firm News
D. Boral to Host Inaugural DBC Conference with Kevin O’Leary
Read More →Firm News
D.Boral is Sole Placement Agent for 374Water’s $12M Offering
Read More →
Press Release
D. Boral Capital Served as Exclusive Placement Agent to Pineapple Financial, Inc. (NYSE: PAPL) in connection with its $1.0 Million Registered Direct Offering
Read More →Firm News
D. Boral Capital LLC Provides Corporate Update, Reporting Strong Revenue Growth & Financial Position
Read More →Firm News
D. Boral Capital LLC to be Platinum Sponsor at The PIPEs Conference
Read More →
Press Release
D. Boral Capital acted as Sole Bookrunner to Nature’s Miracle Holding Inc. (Nasdaq: NMHI) in connection with its $3.0 Million Underwritten Public Offering
Read More →Firm News
EF Hutton LLC Announces Rebranding to D. Boral Capital LLC
Read More →Track Record
Recent Transactions
Recent capital markets transactions by D. Boral Capital.
(Nscale Series Interests)
$2,500,000 Private Offering
(Atoms Series Interests)
~$2,400,000 Private Offering
(Nasdaq: XLAB)
~$630,000,000 Enterprise Value
(Nasdaq: SCATU)
$76,526,300 Initial Public Offering
(Nasdaq: NSAIU)
$100,000,000 Initial Public Offering
(Nasdaq: CHAI)
~$3,500,000 At-the-Market Offering
(Nasdaq: PONOU)
$380,000,000 Business Combination
(Nasdaq: THEOU)
$143,750,000 Initial Public Offering